• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Invitae | Genelex

Invitae | Genelex

Pharmacogenetics Makes Precision Medicine Possible

  • For Patients
    • Conditions
    • Affected Drugs
    • What is PGx?
    • Resources
    • FAQs
  • For Providers
    • Conditions
    • Resources
    • Order Testing Supplies
  • Test Menu
  • Clinical Trials
  • About
    • Lab Accreditations
    • Genelex Team
    • Contact Us
  • Log In

How Genomic Medicine Is Changing the Management of Breast & Ovarian Cancer

Home / News / How Genomic Medicine Is Changing the Management of Breast & Ovarian Cancer

Genelex Blog

How Genomic Medicine Is Changing the Management of Breast & Ovarian Cancer

Our friends at Helix Health, a medical practice with expertise in genomic medicine are hosting a free 90-minute webcast this Wednesday, May 21, 2008 from 1:00-2:30 PM EDT on: How Genomic Medicine Is Changing the Management of Breast & Ovarian Cancer.
To register, point your browser here: http://event.netbriefings.com/event/helixhealth/register.html>.
Join NPR’s David Ewing Duncan, author Jessica Queller and a panel of medical and legal experts in a 90-minute webcast on genetic testing, genomic medicine and breast & ovarian cancer to learn some of the best practices in genomic medicine today from:
Steven A.R. Murphy, MD - Clinical Genetics Fellow at Yale School of Medicine, and Helix Health’s Managing Partner will moderate the panel.
Barbra A. Ward, MD - Director, The Breast Center of Greenwich Hospital; the principal investigator of the STAR Trial at the Yale Cancer Center; prior director of the Yale Comprehensive Breast Care Center and currently a surgical oncologist affiliated with Yale-New Haven Health System.

Jessica Queller - author of Pretty Is What Changes, an account of her valiant decision to accept the results of genetic testing and her difficult decision to undergo a prophylactic double mastectomy. Television writer for Felicity, The Gilmore Girls and One Tree Hill. Writer/producer on Gossip Girl.

Jennifer Ibrahim, MD - clinical geneticist specializing in preconception genetics as well span as familial cancer syndromes.

David Ewing Duncan - bestselling author of Masterminds: Genius, DNA and the Quest to Rewrite Life; Chief Correspondent and co-host of National Public Radio’s Biotech Nation”; Contributing Editor and Columnist, Portfolio; Ditto, Wired; Director, Center for Life Sciences Policy, UC Berkeley; author to articles and short stories, and a television, radio and film producer and correspondent.

Gary E. Marchant - Ph.D. J.D., Lincoln Professor of Emerging Technologies, Law & Ethics, Sandra Day O'Connor College of Law. Executive Director, Center for Law, Science & Technology, Professor, School of Life Sciences Arizona State University.

More information is available on the Helix Health website.

http://www.helixhealth.org/>. If you are unable to attend, a podcast of the session will soon be available.

Genelex Resources

Affected Conditions
Affected Drugs
Info for Providers
Frequently Asked Questions
Contact Genelex
Join Our Mailing List

Footer

CONTACT US

(800) 837-8362
info@genelex.com

3101 Western Ave.
Suite 100
Seattle, WA 98121

HELPFUL INFORMATION

What is PGx?
Test Menu
Conditions
Affected Drugs
FAQs
References

ABOUT GENELEX

Blog
News
Genelex Team
Lab Accreditations
Contact Us
Privacy Practices
Privacy Policy

  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

KEEP IN TOUCH

Stay in the loop with news and updates from Genelex and be among the first to know when new tests become available.